Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

Fidelity Investments reviews Q2 2025 for its Dividend Growth Fund. See how sector shifts and stock picks helped cushion ...

Cal-Maine Foods thrives with zero debt and diversification efforts. Discover its long-term potential despite egg price ...

Super Micro Computer leverages AI demand and innovative cooling tech but faces margin pressures. Read why there are better ...

Conagra's Q4 results and '26 guidance disappointed, yet valuation offers optimism. Explore potential growth via asset sales ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Bank of America’s preferreds offer strong income security and attractive yields, with low redemption risk and solid coverage.

Civeo remains a 'strong buy' despite its financial weakness, as shares trade at attractive valuations and the company is ...

Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

Analyzing weekly Wall Street updates with major stock upgrades and downgrades, including Tesla, Netflix, Lockheed Martin, and ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

Venu Holding faces worsening losses and a complex capital structure that clouds shareholder value despite growth plans. Learn ...